Related Experiment Video
Updated: Mar 2, 2026

08:23
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
10.4K
Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients
Yohann Garnier1, Séverine Ferdinand1, Maryse Etienne-Julan1,2
1Unité Biologie Intégrée du Globule Rouge, Université des Antilles, Inserm 1134, laboratoire d'Excellence GR-Ex, Paris, France.
Plos One
|May 11, 2017
Summary
Microparticle levels in sickle cell anemia (SCA) and hemoglobin SC (HbSC) disease differ, with HbSC patients showing lower concentrations, mainly from red blood cells and platelets. Microparticle levels did not correlate with disease complications in either group.
Area of Science:
- Hematology
- Vascular Biology
- Pediatric Medicine
Background:
- Sickle cell disease (SCD) encompasses sickle cell anemia (SCA) and hemoglobin SC (HbSC) disease, both common hemoglobinopathies with variable clinical courses.
- High microparticle (MP) levels are reported in SCA, linked to complications, but MP patterns in HbSC remain unstudied.
Purpose of the Study:
- To compare microparticle patterns in children with HbSC disease and SCA during steady-state.
- To investigate the association between microparticle concentrations and SCD complications.
Main Methods:
- Flow cytometry was used to analyze circulating microparticle patterns in 84 HbSC and 96 SCA children at steady-state.
- Microparticles were characterized by their cell origin (platelets, red blood cells) and phosphatidylserine exposure.
Main Results:
- Platelet-derived and red blood cell-derived microparticles were the predominant circulating types in both SCA and HbSC.
- HbSC patients had significantly lower total microparticle concentrations than SCA patients, primarily due to reduced red blood cell- and platelet-derived microparticles.
- No correlation was found between microparticle blood concentrations and vaso-occlusive crises, acute chest syndrome, or pulmonary hypertension in either group.
- Red blood cell-derived microparticles were larger and showed higher externalized phosphatidylserine levels than platelet-derived microparticles in both genotypes.
Conclusions:
- Microparticle profiles differ between HbSC disease and SCA, with lower levels observed in HbSC.
- Circulating microparticle concentrations do not appear to predict major SCD complications like vaso-occlusive crises or acute chest syndrome.
- Red blood cell-derived microparticles possess distinct biophysical characteristics compared to platelet-derived microparticles in SCD.

